Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
In a 2022 consent decree reached with the Justice Department, Abbott agreed to replace the plant’s roof, address sanitation protocols and take other corrective steps, though it did not admit liability.
Simplified Text
In a 2022 consent decree with the Justice Department, Abbott agreed to replace its plant's roof and address sanitation, without admitting liability.
Confidence Score
1.000
Claim Maker
The author
Context Type
News Article
Context Details
{
    "year": "2022",
    "parties": [
        "Abbott Laboratories",
        "Justice Department"
    ],
    "document": "Consent decree",
    "agreed_actions": "Replace roof, address sanitation"
}
Subject Tags
Business Regulation Law
UUID
0bc34f32-ebbf-4d8e-bc29-80ae7a26cf77
Vector Index
✗ No vector
Created
September 18, 2026 at 2:01 AM (3 weeks ago)
Last Updated
September 18, 2026 at 2:01 AM (3 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html
Abbott to Pay $385 Million to Settle Infant Formula Allegations
Completed News
12 claims 🔥
3 weeks ago
https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html

Abbott Laboratories will pay nearly $385 million to settle claims that it knowingly sold infant formula manufactured in facilities that did not meet safety requirements. This follows a 2022 recall linked to serious illnesses in babies and a nationwide formula shortage.

Infant Formula Abbott Laboratories Product Safety Recalls Justice Department Public Health

Similar Claims (5)

Other claims identified as semantically similar to this one.